ATRYS HEALTH

-

Close Price Date

-

Close Price

Delisted from BME Growth / Listed on Spanish Stock Exchange

"ATRYS Health specializes in innovative medical diagnostic imaging.and personalized cancer diagnosis and treatments in advanced single-dose radiation therapy company. Our commitment to R & D puts us at the forefront of individualized medicine ."

 

Company Profile

Atrys Health (BME: ATRY), founded in 2015, is a Spanish multinational that provides precision medical prediction, prevention, diagnosis and treatment services. Pioneer in the fields of telemedicine and state-of-the-art radiation therapy.

The company integrates a team of more than 2000 professionals in Spain, Portugal, Switzerland and Latin America.

Atrys structures its prevention and precision activity around five business units: telemedicine, oncology, pathology, prevention and big data. Through these, the company carries out conventional and advanced radiotherapy treatments, performs diagnostic tests in its own network of laboratories, analyzes radiology, cardiology, ophthalmology and dermatology tests electronically, and provides smart and big data to the health sector.

Inside Information

Other Relevant Information

Notices

Relevant Facts until 10/05/2020

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.